Trajectory of renal function change and kidney injury after percutaneous coronary intervention in patients with stable coronary artery disease.
Yuki DeguchiYuichi SaitoMotohiro NakaoHirokazu ShiraishiNaoya SakamotoSatoru KobayashiYoshio KobayashiPublished in: Heart and vessels (2020)
Acute kidney injury usually assessed within 48 h after percutaneous coronary intervention (PCI) is associated with poor clinical outcomes, and persistent kidney damage is also strongly related to long-term mortality. However, little is known about longitudinal renal function change from a very early period to long-term follow-up after PCI. A total of 327 patients with stable coronary artery disease underwent elective PCI. Renal function was assessed with serum creatinine levels and estimated glomerular filtration rate (eGFR) at baseline, 1 day after PCI, at 1 year and at the latest follow-up. Kidney injury was defined as an increase in creatinine levels ≥ 0.3 mg/dl or ≥ 50% from baseline at each timepoint. Major adverse cardiovascular events (MACE) was defined as a composite of death, myocardial infarction, and stroke. eGFR was significantly increased 1 day after PCI, while it was progressively decreased at 1-year and long-term follow-up (median 28 months). Overall, eGFR was declined by - 2.3 ml/min/1.73 m2 per year. Only one (0.3%) patient developed kidney injury 1 day after PCI, whereas kidney injury at 1-year and long-term follow-up was observed in 15 (4.6%) and 27 (8.3%). During the follow-up period, 23 (7.0%) patients had MACE. The incidence of subsequent MACE was significantly higher in patients with kidney injury at 1 year than those without. In conclusion, kidney injury within 24 h after elective PCI was rarely observed. eGFR was progressively decreased over time, and mid-term kidney injury at 1 year was associated with future MACE.
Keyphrases
- coronary artery disease
- percutaneous coronary intervention
- cardiovascular events
- st segment elevation myocardial infarction
- st elevation myocardial infarction
- acute myocardial infarction
- antiplatelet therapy
- coronary artery bypass grafting
- small cell lung cancer
- acute coronary syndrome
- epidermal growth factor receptor
- acute kidney injury
- tyrosine kinase
- atrial fibrillation
- risk factors
- heart failure
- coronary artery bypass
- newly diagnosed
- uric acid
- cardiovascular disease
- aortic stenosis
- type diabetes
- ejection fraction
- metabolic syndrome
- case report
- end stage renal disease
- chronic kidney disease
- emergency department
- electronic health record
- peritoneal dialysis
- adverse drug